top of page
BLACK WITH LOGO (5).png

BACKED BY SCIENCE,
TRUSTED WORLDWIDE

Developed in Italy through years of collaboration between biomedical engineers, physicians, and researchers, Echolight is CE-certified in Europe, FDA-cleared in the United States, and validated in over 100 clinical studies.

 

Its REMS technology is revolutionizing bone health by making assessment safer, more accurate, and more accessible than ever before.

OsteoStrong (1).png

ECHOLIGHT CASE STUDIES

The following peer-reviewed studies and clinical trials highlight Echolight’s accuracy, reliability, and global impact. From early detection of osteoporosis to monitoring long-term bone health, these papers showcase how REMS technology is changing patient care.

Screenshot 2025-09-17 at 12.35.08 PM.png

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis

Screenshot 2025-09-17 at 2.18_edited.png

Radiofrequency echographic multi spectrometry for the prediction of

incident fragility fractures: A 5-year follow-up study

Screenshot 2025-09-17 at 2.20.23 PM.png

Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis

Screenshot 2025-09-17 at 2.28.15 PM.png

Could radiofrequency echographic

multispectrometry (REMS) overcome the overestimation in BMD by dual‑energy X‑ray absorptiometry (DXA) at the lumbar spine?

Screenshot 2025-09-17 at 2.30_edited.jpg

Ability of radiofrequency echographic multispectrometry to identify

osteoporosis status in elderly women with type 2 diabetes

Screenshot 2025-09-17 at 2.38.15 PM.png

Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa

Screenshot 2025-09-17 at 2.41.49 PM.png

Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context 

Screenshot 2025-09-17 at 3.22.14 PM.png

First assessment of bone mineral density in healthy pregnant women by means of Radiofrequency Echographic Multi Spectrometry (REMS) technology

Screenshot 2025-09-17 at 3.24.51 PM.png

Radiofrequency echographic multi-spectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck

Screenshot 2025-09-17 at 3.29.35 PM.png

Radiofrequency echographic multi‑spectrometry for the in‑vivo

assessment of bone strength: state of the art—outcomes of an expert consensus meeting...

Screenshot 2025-09-17 at 3.31.19 PM.png

Radiofrequency echographic multi‑

spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting

Screenshot 2025-09-17 at 3.32.33 PM.png

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art

Screenshot 2025-09-17 at 3.34.32 PM.png

Fragility Score: a REMS‑based indicator for the prediction of incident fragility fractures at 5 years

Screenshot 2025-09-17 at 3.35.39 PM.png

Evaluation of the bone mineral density in the Mexican female population using the Radiofrequency Echographic Multi Spectrometry (REMS) technology

BLACK WITH LOGO (3).png

FROM SCIENCE TO YOUR HEALTH

The evidence is clear: Echolight is transforming the way we understand and protect bone health. Now it’s your turn to benefit from this breakthrough technology.

bottom of page